Compositions and methods for the therapy and diagnosis of...

Details Compositions and methods for the therapy and diagnosis of... Compositions and methods for the therapy and diagnosis of...

2001-12-07

2009-10-06

Epps-Smith, Janet L (Department: 1633)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C435S320100, C435S325000, C536S023100, C536S023500

Reexamination Certificate

active

07598226

ABSTRACT:
Compositions and methods for the therapy and diagnosis of cancer, particularly breast cancer, are disclosed. Illustrative compositions comprise one or more breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly breast cancer.

REFERENCES:
patent: 4962187 (1990-10-01), Pant
patent: 5215926 (1993-06-01), Etchells, III et al.
patent: 5240856 (1993-08-01), Goffe et al.
patent: 5478556 (1995-12-01), Elliott et al.
patent: 5668267 (1997-09-01), Watson et al.
patent: 5843435 (1998-12-01), Slavin
patent: 5855889 (1999-01-01), Watson et al.
patent: 5861381 (1999-01-01), Chambon et al.
patent: 5891857 (1999-04-01), Holt et al.
patent: 5922836 (1999-07-01), Watson et al.
patent: 5968754 (1999-10-01), Watson et al.
patent: 5981731 (1999-11-01), Monia
patent: 5986170 (1999-11-01), Subjeck
patent: 6004756 (1999-12-01), Watson et al.
patent: 6150168 (2000-11-01), Woo et al.
patent: 6153386 (2000-11-01), Lalouel et al.
patent: 6387697 (2002-05-01), Yuqiu et al.
patent: 6518237 (2003-02-01), Yuqiu et al.
patent: 6528054 (2003-03-01), Jiang et al.
patent: 6573368 (2003-06-01), Yuqiu et al.
patent: 6579973 (2003-06-01), Yuqiu et al.
patent: 6586572 (2003-07-01), Jiang et al.
patent: 6590076 (2003-07-01), Yuqiu et al.
patent: 6680197 (2004-01-01), Jiang et al.
patent: 6756477 (2004-06-01), Jiang et al.
patent: 6844325 (2005-01-01), Jiang et al.
patent: 6958361 (2005-10-01), Houghton et al.
patent: 6969518 (2005-11-01), Houghton et al.
patent: 2002/0009738 (2002-01-01), Houghton et al.
patent: 2002/0150581 (2002-10-01), Jiang et al.
patent: 2003/0170631 (2003-09-01), Houghton et al.
patent: 2226901 (1998-07-01), None
patent: 2226910 (1998-10-01), None
patent: 2284642 (1998-10-01), None
patent: WO 89/06280 (1989-07-01), None
patent: WO 91/16116 (1991-10-01), None
patent: WO 91/16629 (1991-10-01), None
patent: WO 92/07243 (1992-04-01), None
patent: WO 96/29430 (1996-09-01), None
patent: WO 97/02280 (1997-01-01), None
patent: WO 97/22349 (1997-06-01), None
patent: WO 97/25426 (1997-07-01), None
patent: WO 97/25431 (1997-07-01), None
patent: WO 98/04742 (1998-02-01), None
patent: WO 98/21331 (1998-05-01), None
patent: WO 98/24928 (1998-06-01), None
patent: WO 98/33915 (1998-08-01), None
patent: WO 98/45328 (1998-10-01), None
patent: WO 98/54963 (1998-12-01), None
patent: WO 99/09155 (1999-02-01), None
patent: WO 99/14230 (1999-03-01), None
patent: WO 00/08210 (2000-02-01), None
patent: WO 00/37643 (2000-06-01), None
patent: WO 00/43420 (2000-07-01), None
patent: WO 00/60076 (2000-10-01), None
patent: WO 00/73801 (2000-12-01), None
patent: WO 01/37779 (2001-05-01), None
patent: WO 01/47959 (2001-07-01), None
patent: WO 01/51628 (2001-07-01), None
patent: WO 01/57270 (2001-08-01), None
patent: WO 01/75171 (2001-10-01), None
patent: WO 01/79286 (2001-10-01), None
patent: WO 02/059377 (2002-08-01), None
patent: WO 02/083956 (2002-10-01), None
Adams et al. GenBank Accession No. B15703. 1997.
Adams et al. GenBank Accession No. B17512. 1997.
Chen et al. GenBank Accession No. X88318.1.
Adams et al. GenBank Accession No. AQ280806.
Nyberg et al. Workshop on Long-Term Follow-up of Participants in Human Gene Transfer Research. Molecular Therapy. vol. 10., No. 6, Dec. 2004, pp. 976-980.
Gura (Science, 1997, vol. 278, pp. 1041-1042).
Hartwell et al. (Science, 1997, vol. 278, pp. 1064-1068).
GenBank Accession No. AI951118. (First appeared in GenBank-NCBI on Aug. 19, 1999).
Anderson, W. French. Human Gene Therapy. Apr. 30, 1998, Nature, vol. 392, pp. 25-30.
Mullins JJ et al. Hypertension 22:630-633, 1993.
Cameron ER. Molecular Biotechnology 7:253-265, 1997.
Hammer RE et al. Cell 63:1099-1112. 1990.
Smith. Journal of Biotechnology 99: 1-22, 2002.
Gardner et al. International Journal of Developmental Biology. (1997), vol. 41, pp. 235-243.
GenBank Accession No. AI687645, May 27, 1999.
GenBank Accession No. AQ280806, Nov. 22, 1998.
Genseq (Derwent) Accession No. AAV90219, Feb. 15, 1999.
GenBank Accession No. AC069200, May 24, 2000.
Sulston et al., “Toward a complete human genome sequence,”Genome Research 8(11):1097-1108, 1998.
GenBank Accession No. AL157387, Feb. 18, 2000.
GenBank Accession No. AC036170, Apr. 9, 2000.
Chang and Shu, “Current status of adoptive immunotherapy of cancer,”Critical Reviews in Oncology/Hematology 22(3):213-228, Apr. 1996.
Cheever and Chen, “Therapy with cultured T cells: principles revisited,”Immunological Reviews, 157: 177-194, 1997.
Cheever et al., “Potential uses of interleukin 2 in cancer therapy,”Immunobiol, 172:365-382, 1986.
Chen et al., “T-cells for tumor therapy can be obtained from antigen-loaded sponge implants,”Cancer Research 54(4):1065-1070, Feb. 15, 1994.
Cole et al., “Characterization of the functional specificity of a cloned T-cell receptor heterodimer recognizing the MART-1 melanoma antigent,”Cancer Research, 55:748-752, Feb. 15, 1995.
Durrant L., “Cancer vaccines,”Anti-Cancer Drugs, 8:727-733, 1997.
Eshhar Z., “Tumor-specific T-bodies: toward clinical application,”Cancer Immunol Immnother, 45:131-136, 1997.
GenBank Accession No. AF269087, Mar. 28, 2001.
GenBank Accession No. AAK27325, Mar. 28, 2001.
GenBank Accession No. AA864891, Feb. 20, 1998.
GenBank Accession No. AA398925, Apr. 25, 1997.
Geneseq Accession No. V84525 (Dec. 10, 1998).
Hwu et al., “In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes,”Cancer Research, 55:3369-3373, Aug. 1, 1995.
Porter-Jordan and Lippman, “Overview of the biologic markers of breast cancer,”Breast Cancer 8:(1):73-100, Feb. 1994.
Prilliman et al., “HLA-B15 peptide ligands are preferentially anchored at their c termini,”The Journal of Immunology 162(12):7277-7284, Jun. 15, 1999.
Stratagene 1991 product catalog, Prime-It™ Random Labeling Kit, catalog No. 300387, p. 66.
Wei et al., “Protection against mammary tumor growth by vaccination with full-length, modified humanErbB-2DNA,”Int. J. Cancer, 81:748-754, 1999.
GenBank Accession No. AL359312, Dec. 7, 2001.
Jäger et al., “Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library,”Cancer Research 61(5):2055-2061, Mar. 1, 2001.
GenBank Accession No. AF269087, Mar. 28, 2001.
Alberts et al. Mol. Biol. Cell, 3rded., p. 455, 1994.
Anderson and Seilhamer, “A comparison of selected MRNA and protein abundances in human liver”,Electrophoresis18: 533-537, 1997.
Boon, T., “Toward a Genetic Analysis of Tumor Rejection Antigens”,Adv. Cancer Res.58: 177-210, 1992.
Bork, P., “Powers and Pitfalls in Sequence Analysis: The 70% Hurdle”,Genome Research10(4): 398-400, Apr. 2000.
Burgess, W.H. et al., “Possible Dissociation of the Heparin-binding and Mitogenic Activities of Heparin-binding (Acidic Fibroblast) Growth Factor-1 from Its Receptor-binding Activities by Site-directed Mutagenesis of a Single Lysine Residue”,Journal of Cell Biology111:2129-2138, Nov. 1990.
Cheli et al.,Clin Chem. 44(4): 765-72, 1998.
Conner et al.,Mol Brain Res. 42: 1-17, 1996.
Curti, B.D., “Physical barriers to drug delivery in tumors”,Critical Reviews in Oncology/Hematology14: 29-39, 1993.
Dermer.,Bio/Technol. 12: 320, 1994.
Doerks, T. et al., “Protein annotation: detective work for function prediction”,Trends in Genetics14(6): 248-250, Jun. 1998.
Ezzell, C., “Cancer ‘Vaccines’: An Idea Whose Time Has Come?”The Journal of NIH Research7: 46-49, Jan. 1995.
Freshney, Cult. Animal Cells, A Manual of Basic Technique, Alan R. Lisc. Inc. p. 4, 1983.
Fu et al.,EMBO J. 15: 4392-4401, 1996.
Gaubin et al.,J Immunol.1999, 162(5): 2631-8.
Ge

Affiliated with

Also associated with

Rating

Compositions and methods for the therapy and diagnosis of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for the therapy and diagnosis of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the therapy and diagnosis of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4095714